Lv7
5000 积分 2024-05-26 加入
Metabolite profiling of remibrutinib in rat and human liver microsomes using liquid chromatography combined with benchtop orbitrap high‐resolution mass spectrometry
1个月前
已完结
Effects of ANGPTL3 Antisense Oligodeoxynucleotides Transfection on the Cell Growths and Invasion of Human Hepatocellular Carcinoma Cells
5个月前
已关闭
Memory T Cells in Rhesus Macaques
5个月前
已完结
对KUF10全自动化大便分析仪在隐血检测临床应用的探讨
6个月前
已完结
药物致癌性试验指导原则修订情况介绍
6个月前
已完结
1532例粪便常规检查和801例隐血试验结果的分析
6个月前
已完结
粪便常规检查和隐血试验结果的分析
6个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
7个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
7个月前
已完结
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
9个月前
已完结
皖公网安备34019202002308
